Literature DB >> 22357139

Anti-CD22 therapy in acute lymphoblastic leukaemia.

Dieter Hoelzer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22357139     DOI: 10.1016/S1470-2045(12)70010-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

Review 1.  Drug discovery and therapeutic delivery for the treatment of B and T cell tumors.

Authors:  Regan Stephenson; Ankur Singh
Journal:  Adv Drug Deliv Rev       Date:  2017-06-15       Impact factor: 15.470

Review 2.  Novel CD20 monoclonal antibodies for lymphoma therapy.

Authors:  Shundong Cang; Nikhil Mukhi; Kemeng Wang; Delong Liu
Journal:  J Hematol Oncol       Date:  2012-10-11       Impact factor: 17.388

3.  Adenovirus carrying gene encoding Haliotis discus discus sialic acid binding lectin induces cancer cell apoptosis.

Authors:  Xinyan Yang; Liqin Wu; Xuemei Duan; Lianzhen Cui; Jingjing Luo; Gongchu Li
Journal:  Mar Drugs       Date:  2014-06-30       Impact factor: 5.118

4.  The Influence of B Cell Depletion Therapy on Naturally Acquired Immunity to Streptococcus pneumoniae.

Authors:  Giuseppe Ercoli; Elisa Ramos-Sevillano; Rie Nakajima; Rafael Ramiro de Assis; Algis Jasinskas; David Goldblatt; Philip Felgner; Gisbert Weckbecker; Jeremy Brown
Journal:  Front Immunol       Date:  2021-01-28       Impact factor: 7.561

5.  Maintained partial protection against Streptococcus pneumoniae despite B-cell depletion in mice vaccinated with a pneumococcal glycoconjugate vaccine.

Authors:  Giuseppe Ercoli; Elisa Ramos-Sevillano; Emma Pearce; Sara Ragab; David Goldblatt; Gisbert Weckbecker; Jeremy S Brown
Journal:  Clin Transl Immunology       Date:  2021-12-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.